FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer. - Wikidata - wikimedia - TriplyDB

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

http://www.wikidata.org/entity/Q34543873

about

Tumor Hypoxia Regulates Forkhead Box C1 to Promote Lung Cancer Progression FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways Identification of EGF-NF-κB-FOXC1 signaling axis in basal-like breast cancer.Basal Protein Expression Is Associated With Worse Outcome and Trastuzamab Resistance in HER2+ Invasive Breast Cancer.MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer.FOXC1 identifies basal-like breast cancer in a hereditary breast cancer cohort.BCIP: a gene-centered platform for identifying potential regulatory genes in breast cancer.FOXC1: an emerging marker and therapeutic target for cancer.Knockdown of long non-coding RNA XIST increases blood-tumor barrier permeability and inhibits glioma angiogenesis by targeting miR-137.FOXC1 in cancer development and therapy: deciphering its emerging and divergent roles.Forkhead box protein C1 promotes cell proliferation and invasion in human cervical cancer.Characterization of primary human mammary epithelial cells isolated and propagated by conditional reprogrammed cell culture.FOXC1, the new player in the cancer sandbox.Research progress on the forkhead box C1.Down-regulation of MicroRNA-133 predicts poor overall survival and regulates the growth and invasive abilities in glioma.Silencing FOXC1 inhibits growth and migration of human oral squamous cell carcinoma cells Long noncoding RNA SNHG6 promotes the progression of colorectal cancer through sponging miR-760 and activation of FOXC1

P2860

Q33588186-BE78CFB6-D52F-4691-8A5F-5D06641408AC Q33710341-901C7B10-8643-45A3-8645-FC8347443A24 Q33737298-81AE2511-F58D-4B05-A682-6C0EE5416251 Q33814357-11B08F9D-6173-4C12-B703-AFAACD19F480 Q36279794-18C87285-F1DD-4279-8616-DE09473897A3 Q36827700-C23DCBC2-E581-4748-9BB4-3CD1A12CA90E Q37689013-16729A77-7CE7-443F-8B6C-CAE58C2AB793 Q37714913-30133DEB-3A44-4DFE-BC0C-90C38D5900E5 Q39176111-9F703F38-7623-4700-A63B-0B24526A644E Q42339290-728A2304-3388-4688-9FCF-0C5722EED1C2 Q49624286-207639BF-CB4F-4935-88AC-BC5BD372278B Q50068119-8B401C0E-36CF-4783-AF75-49E53B3F01E4 Q52653019-38060F02-0665-41D5-9FA7-26741B531C37 Q52682253-FE59DE1A-53C4-4973-8875-E6A551491B0A Q53701147-74019D26-5829-4F40-8071-60F09D77FFC1 Q55458536-FA393A4C-CF58-4C42-8274-2B8276533A0C Q58733344-9C028919-1137-4A4E-A067-BA01B3954155 Q58746865-8547E4F9-D2AE-4224-A202-D176ECF6C399

P2860

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

http://www.wikidata.org/entity/Q34543873

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@ast

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@en

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@nl

type

label

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@ast

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@en

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@nl

prefLabel

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@ast

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@en

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@nl

P1433

Q34543873-B9EF3854-3CDC-4B96-81CF-5BD6B2A16BBD

P1476

Q34543873-D852B51A-7783-4AD6-AC6D-0B21E12148C4

P2093

Q34543873-184A726E-F4D7-4851-832F-EB9FA1E6AA8A

Q34543873-23FF893C-202C-4658-B53F-243424566EF3

Q34543873-26CC0342-A9D2-4201-8F0E-7152BF06888D

Q34543873-50A870A3-498D-47F2-902F-648780C8A9DA

Q34543873-68897141-EEA7-4DDB-9592-EA5F31EB1892

Q34543873-6BBB6129-A854-448A-AC23-B5E8A10050AD

Q34543873-B46431BE-FF4E-47D7-ADA0-9891C036F44C

Q34543873-BB4977EF-A78F-4A94-B3D1-8716521D0731

Q34543873-DF50D93B-CB12-4E7B-8EBC-007F85031E88

Q34543873-E4FB980A-F551-4359-9209-8C9FEAF1760F

P2860

Q34543873-04D9AF6A-3C4E-4162-BDBE-8D315099372A

Q34543873-07C93B0E-F59F-4DA2-B0FE-F47BA3CE4C37

Q34543873-14DE7E83-4F21-4E57-8643-2A0728FC0394

Q34543873-202A31AB-A57C-494C-9306-2C8AA341B97A

Q34543873-213E6818-EC47-4901-83F5-856897917608

Q34543873-22CC6576-DC37-42B4-8089-A94F99178240

Q34543873-26B8E3F9-6867-4939-8266-3E2884A6D0CD

Q34543873-2769B8D0-68D6-4F10-8DAC-C7EECE694CBF

Q34543873-294751DD-8325-4838-8396-DCF9D03EAC22

Q34543873-2F272CE2-C04F-428C-83F9-AF43C63B37C2

P2888

Q34543873-0BFDF04D-BD8E-4FEB-94F3-4D80B279C9C6

P304

Q34543873-6AB9D9E9-1E37-47AA-A5D0-38E048F90B08

P31

Q34543873-F2DC3E16-E9C1-41F3-961B-90FA96AF8CAC

P356

Q34543873-E1A86411-7CAB-4416-8AF4-DA3E576FB2C6

P478

Q34543873-351B8892-3804-4E2C-952D-F9263145EB14

P577

Q34543873-2B7745C3-41C8-4B36-BD6D-2E7BC91F426B

P5875

Q34543873-C1889246-9009-4E61-9819-1A920BDF356B

P6179

Q34543873-0E654C75-492F-484B-BD1B-B9991088597B

P698

Q34543873-6545F20E-46AB-4845-9CB8-8643837E6140

P932

Q34543873-0DEEC745-A988-42E1-A7D5-66DB077C64C8

P356

S10434-014-3980-3

P1433

Annals of Surgical Oncology

P1476

FOXC1 is a critical mediator of EGFR function in human basal-like breast cancer.

@en

P2093

Armando E Giuliano

http://www.w3.org/2001/XMLSchema#string

Beth Y Karlan

http://www.w3.org/2001/XMLSchema#string

Bingchen Han

http://www.w3.org/2001/XMLSchema#string

Jiongyu Chen

http://www.w3.org/2001/XMLSchema#string

Ruprecht Wiedemeyer

http://www.w3.org/2001/XMLSchema#string

Sandra Orsulic

http://www.w3.org/2001/XMLSchema#string

Shikha Bose

http://www.w3.org/2001/XMLSchema#string

Xiao Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaojiang Cui

http://www.w3.org/2001/XMLSchema#string

Yanli Jin

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly.

FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer

Comprehensive molecular portraits of human breast tumours

The emerging roles of forkhead box (Fox) proteins in cancer

Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma

The forkhead/winged helix gene Mf1 is disrupted in the pleiotropic mouse mutation congenital hydrocephalus

Targeting the phosphoinositide 3-kinase pathway in cancer

Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition

Matrix metalloproteinases and the regulation of tissue remodelling

EGF-ERBB signalling: towards the systems level

P2888

s10434-014-3980-3

P304

S758-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-014-3980-3

http://www.w3.org/2001/XMLSchema#string

P478

21 Suppl 4

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264833615

http://www.w3.org/2001/XMLSchema#string

P6179

1010329142

http://www.w3.org/2001/XMLSchema#string

P698

25124473

http://www.w3.org/2001/XMLSchema#string

P932

4237705

http://www.w3.org/2001/XMLSchema#string